Tuesday, May 17, 2016

Ultratech Cambridge Nanotech Forms Research Collaboration With Northeastern University

Ultratech-CNT and Professor Thomas Webster at Northeastern University to Research the Use of ALD-Produced Nano-Materials in Medical Applications

SAN JOSE, Calif., May 17, 2016 /PRNewswire/ -- Ultratech, Inc. (Nasdaq: UTEK), a leading supplier of lithography, laser­ processing and inspection systems used to manufacture semiconductor devices and high­brightness LEDs (HB­ LEDs), as well as atomic layer deposition (ALD) systems, announced the formation of a research collaboration with Professor Thomas J. Webster, Ph.D. at Northeastern University, to study the use of nano-materials produced via ALD for medical applications. The initial research has focused on inhibiting bacterial growth and inflammation and promoting cell and tissue growth. 
 
 
Dr. Thomas Webster, Chair and Professor of Chemical Engineering at Northeastern, said, "We are very excited to embark on this collaboration with Ultratech-CNT. While we are in the early stages of this study, the initial results of our work suggest that the materials and processes we are developing could have long-range impact in this field."


 
Ultratech-CNT Senior Research Scientist Ritwik Bhatia, Ph.D., who has been working closely with Professor Webster, explained, "This type of work is a marked departure from the traditional applications and uses for ALD and dramatically opens up a new field where material science and life sciences intersect. I am extremely pleased to be part of this research program and excited by the potential benefits for healthy surgical outcomes that this research represents."

Arthur W. Zafiropoulo, Ultratech's Chairman and Chief Executive Officer, said, "At Ultratech, we have long maintained and understood that material science would play a key role in moving many emerging technological fields forward. We also feel that it can serve a much larger role, namely in improving the quality of life. In linking the expertise of Prof. Webster and his research group with Ultratech-CNT's ALD group, we believe we are taking steps to solidly and efficiently pursue our scientific and commercial goals."